Stryker Corp SYK is on an acquisition spree. The company recently announced plans to acquire the neuro product portfolio of Synergetics USA, which will add products like Malis generator and Spetzler ...

Stryker's recharged organic growth prospects continue to support a solid long-term investing proposition. While Stryker lags both Johnson & Johnson and Medtronic pretty significantly in spine, Stryker ...

Stryker ($SYK) announced a tuck-in acquisition, saying it has agreed to acquire all of the assets in Synergetics USA's neurology portfolio, which achieved sales of ...

Stryker's 7% organic revenue growth was impressive, supported by ongoing MAKO-driven share gains in knees, strong power tool performance, and continued strength in neuro. Stryker continues to produce ...

The "Stereotactic Neuro-Navigation System Market - A Global and Regional Analysis: Focus on Product, Application, End User, and Region - Analysis and Forecast, 2025-2035" report has been added to ...

Stryker posted impressive top-line growth in Q4, driven by mid-teens growth in the MedSurg & Neuro operations. Margins remain a drag as Stryker has struggled to offset higher input costs. I see upside ...